In chronic lymphocytic leukemia, the PIM inhibitor SGI-1776 induces apoptosis by decreasing Mcl1 express via a global block in RNA synthesis, and in multiple myeloma the mechanism of action is by blocking translation and inducing autophagy [55, 56]. The gene discussed is PIM1; the disease is plasma cell myeloma.